Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01626391
What this trial is testing

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 9
Early research (Phase 1)Study completedNCT00675090
What this trial is testing

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 28
Early research (Phase 1)UnknownNCT05016427
What this trial is testing

Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
VTBIO Co. LTD 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Large-scale testing (Phase 3)Ended earlyNCT02248116
What this trial is testing

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 198
Testing effectiveness (Phase 2)Study completedNCT03462121
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

Who this might be right for
Mild to Moderate Dementia Due to Alzheimer's DiseaseWith or Without Coexisting Cerebrovascular Disease
Regenera Pharma Ltd 83
Not applicableEnrolling By InvitationNCT06245031
What this trial is testing

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Who this might be right for
Alzheimer DiseaseCognitive ImpairmentMild Cognitive Impairment+5 more
Cognito Therapeutics, Inc. 402
Not applicableUnknownNCT05527587
What this trial is testing

The Effects of a Park Visit Program on Individuals With Dementia and Their Caregivers

Who this might be right for
Mild DementiaModerate DementiaAlzheimer Disease
University of Calgary 20
Testing effectiveness (Phase 2)Study completedNCT00100334
What this trial is testing

Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
PRAECIS Pharmaceuticals Inc. 24
Large-scale testing (Phase 3)Study completedNCT00675623
What this trial is testing

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 598
Testing effectiveness (Phase 2)UnknownNCT03806478
What this trial is testing

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
DementiaAlzheimer Disease 1Alzheimer Disease 2+1 more
Aphios 60
Testing effectiveness (Phase 2)Study completedNCT01078168
What this trial is testing

Alzheimer's Disease Acitretin Medication

Who this might be right for
Alzheimer Disease
K. Lieb 22
Testing effectiveness (Phase 2)Study completedNCT03507790
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Cognition Therapeutics 153
Not applicableStudy completedNCT02978768
What this trial is testing

Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chang Gung Memorial Hospital 67
Not applicableUnknownNCT04938271
What this trial is testing

A Telehealth Study of a Wearable Electroceutical & Sports Sleeve for Knee Osteoarthritis Pain Relief & Improved Function

Who this might be right for
Osteoarthritis, Knee
Healables Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03605667
What this trial is testing

Study of BHV-4157 in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Biohaven Pharmaceuticals, Inc. 350
Testing effectiveness (Phase 2)WithdrawnNCT01066481
What this trial is testing

Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaDimebon+1 more
Pfizer
Large-scale testing (Phase 3)Study completedNCT00277810
What this trial is testing

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 250
Early research (Phase 1)Study completedNCT02640092
What this trial is testing

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 72
Next Page